Quamed

QUAMED joins the Global Health Supplies discussion on Nov 28th 2022

The QUAMED director Ed Vreeke participates in the Joint UNICEF, UNFPA and WHO meeting with manufacturers and suppliers in Copenhagen ( 28 November-01 December 2022). The title of the meeting is Global Health Supplies: Paradigm Shifts in Market Authorization, Procurement and Supply Chains Approach. We are represented to learn more about the quality assurance systems of suppliers and the QA needs of procurers ...

QUAMED becomes part of WHO’s Coalition of Interested Parties (CIP)

QUAMED is part of the World Health Organization’s Coalition of Interested Parties  As formulated by the WHO: “The purpose of CIP is to establish and promote a unified, strategic and coordinated approach to national and regional RSS, with a view to enhancing access to safe, effective and quality medical products”. This aligns perfectly with our vision and ...

WHO Alert for Sub-standard Medical Product

The WHO Medical Product Alert refers to 8 sub-standard products, identified in South-East Asia. These products were identified in Indonesia and reported by the natural regulatory authority (Badan POM) on 20 and 30 Oct 2022. The 8 products were: Termorex syrup, Flurin DMP syrup, Unibebi Cough Syrup, Unibebi Demam Paracetamol Drops, Unibebi Demam Paracetamol Syrup, ...

Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.